1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Reply to “Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry”
(
- Contribution to journal › Article
-
Mark
Exploring Definitions and Predictors of Response to Biologics for Severe Asthma
2024) In Journal of Allergy and Clinical Immunology: In Practice(
- Contribution to journal › Article
- 2023
-
Mark
Trends in Treatments With Disease-Specific and Interfering Drugs in Patients With Hereditary Angioedema in Sweden
(
- Contribution to journal › Article
-
Mark
Impact of Inititing Biologics in Patients With Severe Asthma on Long-term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
(
- Contribution to journal › Article
- 2022
-
Mark
Impact of dupilumab on SNOT-22 sleep and function scores in CRSwNP
(
- Contribution to journal › Article
- 2021
-
Mark
Risk of Rehospitalization and Death in Patients Hospitalized Due to Asthma
(
- Contribution to journal › Article
- 2020
-
Mark
Research Priorities in Pediatric Asthma : Results of a Global Survey of Multiple Stakeholder Groups by the Pediatric Asthma in Real Life (PeARL) Think Tank
(
- Contribution to journal › Article
- 2018
-
Mark
Relationship of Inhaled Corticosteroid Adherence to Asthma Exacerbations in Patients with Moderate-to-Severe Asthma
(
- Contribution to journal › Article
- 2017
-
Mark
Long-term Safety and Efficacy of Reslizumab in Patients with Eosinophilic Asthma
(
- Contribution to journal › Article